BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17721373)

  • 1. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
    Rondinelli PI; Ribeiro Kde C; de Camargo B
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive fungal infections in children with cancer, neutropenia and fever, in Chile].
    Lucero Y; Brücher R; Alvarez AM; Becker A; Cofré J; Enríquez N; Payá E; Salgado C; Santolaya ME; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; O'Ryan M
    Rev Med Chil; 2002 Oct; 130(10):1139-46. PubMed ID: 12491831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
    Akova M; Paesmans M; Calandra T; Viscoli C;
    Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    Clin Infect Dis; 2002 Sep; 35(6):678-83. PubMed ID: 12203164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of bacteremia in febrile neutropenic episodes in children with cancer: microbiologic and molecular approach.
    Santolaya ME; Farfán MJ; De La Maza V; Cociña M; Santelices F; Alvarez AM; Avilés CL; Becker A; O'Ryan M; Román P; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Torres JP
    Pediatr Infect Dis J; 2011 Nov; 30(11):957-61. PubMed ID: 21768922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
    Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation.
    Villarroel M; Avilés CL; Silva P; Guzmán AM; Poggi H; Alvarez AM; Becker A; O'ryan M; Salgado C; Topelberg S; Tordecilla J; Varas M; Viviani T; Zubieta M; Santolaya ME
    Pediatr Infect Dis J; 2010 Sep; 29(9):816-21. PubMed ID: 20616763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia.
    Torres JP; Labraña Y; Ibañez C; Kasaneva P; Farfán MJ; De la Maza V; Villarroel M; Vergara I; Piemonte P; Zubieta M; Salgado C; Tordecilla J; Topelberg S; O Ryan M; Santolaya ME
    Pediatr Infect Dis J; 2012 Sep; 31(9):889-93. PubMed ID: 22565292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with life-threatening infections in children with febrile neutropenia: a data mining approach.
    Badiei Z; Khalesi M; Alami MH; Kianifar HR; Banihashem A; Farhangi H; Razavi AR
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e9-e12. PubMed ID: 21102352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk prediction in pediatric cancer patients with fever and neutropenia.
    Hakim H; Flynn PM; Srivastava DK; Knapp KM; Li C; Okuma J; Gaur AH
    Pediatr Infect Dis J; 2010 Jan; 29(1):53-9. PubMed ID: 19996816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology and mortality of pediatric febrile neutropenia in El Salvador.
    Gupta S; Bonilla M; Gamero M; Fuentes SL; Caniza M; Sung L
    J Pediatr Hematol Oncol; 2011 May; 33(4):276-80. PubMed ID: 21516023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
    Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
    Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Length of stay and mortality associated with febrile neutropenia among children with cancer.
    Basu SK; Fernandez ID; Fisher SG; Asselin BL; Lyman GH
    J Clin Oncol; 2005 Nov; 23(31):7958-66. PubMed ID: 16258096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
    Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
    Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever.
    Santolaya ME; Alvarez AM; Becker A; Cofré J; Enríquez N; O'Ryan M; Payá E; Pilorget J; Salgado C; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    J Clin Oncol; 2001 Jul; 19(14):3415-21. PubMed ID: 11454890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.